Evidence map›Paper›PMID 30455327›Full record

Observational studyDiabetes care2019

Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I.

Wendy A Davis, Emma J Hamilton, David G Bruce, Timothy M E Davis

Abstract readObservational StudyValidation Study
PubMed Publisher
In one paragraph

Observational study in Diabetes care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Assessment of fracture risk in diabetic patients.Journal of diabetes and metabolic disorders · 2024
    Review
  6. Review
  7. Review
  8. Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  9. Article
  10. Diabetes and bone.Osteoporosis and sarcopenia · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Wendy A DavisMedical School, The University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia.
Emma J HamiltonMedical School, The University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia.
David G BruceMedical School, The University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia.ORCID 0000-0002-9979-6867
Timothy M E DavisMedical School, The University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia tim.davis@uwa.edu.au.ORCID 0000-0003-0749-7411

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop a type 2 diabetes hip fracture risk tool in community-based patients, to validate it in an independent cohort, and to compare its performance against the only published prediction equation to include type 2 diabetes as a risk factor (QFracture). RESEARCH DESIGN AND

methodsHip fracture hospitalizations in 1,251 participants with type 2 diabetes aged 40-89 years from the longitudinal Fremantle Diabetes Study Phase I (FDS1) were ascertained between entry (1993-1996) and end-2012. Competing risk regression modeling determined independent predictors of time to first fracture over 10 years and the coefficients incorporated in a risk model. The model was validated in 286 participants with type 2 diabetes from the Busselton Health Study (BHS).

resultsFifty FDS1 participants (4.0%) experienced a first hip fracture during 10,306 person-years of follow-up. Independent predictors of fracture were older age, female sex, lower BMI, peripheral sensory neuropathy, and estimated glomerular filtration rate <45 mL/min/1.73 m

conclusionsThe FDS1 hip fracture risk equation is a simple validated adjunct to type 2 diabetes management that uses variables that are readily available in routine care.

Indexed as

AdultAgedAged, 80 and overAustraliaBiomarkersCalibrationComorbidityDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlycated HemoglobinHip FracturesHospitalizationHumansLongitudinal StudiesMaleBiomarkersGlycated Hemoglobin

Identifiers

PMID30455327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.